Dual-color, Break-apart FISH Assay on Paraffin-embedded Tissues as an Adjunct to Diagnosis of Xp11 Translocation Renal Cell Carcinoma and Alveolar Soft Part Sarcoma

Both Xp11.2 translocation renal cell carcinoma (RCC) and alveolar soft part sarcoma (ASPS) are characterized by various translocations disrupting chromosome Xp11.2, which result in gene fusions involving the TFE3 transcription factor gene. Diagnostic tools to detect translocations involving the TFE3...

Full description

Saved in:
Bibliographic Details
Published in:The American journal of surgical pathology Vol. 34; no. 6; pp. 757 - 766
Main Authors: MINGHAO ZHONG, DE ANGELO, Patricia, HAMEED, Meera, OSBORNE, Lisa, KEANE-TARCHICHI, Megan, GOLDFISCHER, Michael, EDELMANN, Elisa, YOUFENG YANG, LINEHAN, W. Marston, MERINO, Maria J, AISNER, Seena
Format: Journal Article
Language:English
Published: Hagerstown, MD Lippincott Williams & Wilkins 01-06-2010
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Both Xp11.2 translocation renal cell carcinoma (RCC) and alveolar soft part sarcoma (ASPS) are characterized by various translocations disrupting chromosome Xp11.2, which result in gene fusions involving the TFE3 transcription factor gene. Diagnostic tools to detect translocations involving the TFE3 gene on chromosome X would be valuable in the evaluation of these tumors. We developed a dual-color, break-apart fluorescence in situ hybridization (FISH) assay to identify the chromosomal break point in paraffin-embedded tissue. This assay was validated using 4 cases of Xp11.2 RCC [proven by karyotype and/or reverse-transcriptase polymerase chain reaction (RT-PCR)], 2 cases of ASPS (proven by karyotype or RT-PCR), the UOK109 cell line carrying the inv(X) (p11;q12), and several negative controls (both neoplastic and non-neoplastic). This break-apart FISH assay is a relatively quick procedure for detecting Xp11.2 RCC and ASPS translocations and can be applied to archival paraffin-embedded tissue.
ISSN:0147-5185
1532-0979
DOI:10.1097/pas.0b013e3181dd577e